May 8, 2025
Envol Biomedical is proud to announce its role as a founding member of the LNP Alliance, a powerful new collaboration alongside Phosphorex, NOF CORPORATION, NeoSome Life Sciences, and NanoImaging Services (NIS). Together, these five industry leaders are combining forces to transform lipid nanoparticle (LNP) technology and accelerate the delivery of next-generation therapeutics.
Click here to read the official press release announcement
For Envol Biomedical, this alliance marks a strategic evolution of its services and a major advantage for its clients—particularly those navigating the increasingly complex world of biologics, gene therapies, and advanced drug delivery systems.
Why the LNP Alliance Matters
The LNP Alliance brings together unrivaled expertise across the entire LNP development value chain, offering:
- Proprietary lipid innovation for optimized drug delivery
- Expert formulation and process development to enhance stability and efficacy
- Integrated analytical, manufacturing, and scale-up services
- Advanced cryo-TEM imaging for precise nanoparticle characterization
- Biodistribution, efficacy, and toxicology evaluations—including Non-Human Primate (NHP) studies provided by Envol Biomedical
This end-to-end solution empowers biopharma and biotech companies to move confidently and efficiently from discovery through preclinical development and into the clinic.
Amplifying Envol Biomedical’s Value to Clients
For years, Envol Biomedical has set itself apart through its specialized pharmacology and toxicology research in NHPs, rapid turnaround times, and cost-effective study designs. With over 75,000 square feet of lab space, a highly experienced team, and capabilities spanning multiple dose routes, disease models, and surgical services, Envol has become the go-to partner for companies seeking fast, reliable answers to guide their dosing strategies and ensure patient safety.
By joining the LNP Alliance, Envol significantly amplifies the resources and expertise available to its clients, offering:
- Seamless access to world-class LNP formulation and manufacturing experts through Phosphorex and NOF CORPORATION
- Streamlined project coordination from formulation to in vivo evaluation, reducing delays and accelerating development timelines
- Next-generation nanoparticle characterization with NanoImaging Services, ensuring the highest data integrity for regulatory filings
- Integrated biodistribution and efficacy studies with NeoSome Life Sciences, complemented by Envol’s unparalleled NHP models
For existing Envol clients, this means a single, unified pathway from bench to bedside—without the need to manage multiple vendors or coordinate between disconnected service providers.
Bringing Gene Therapy, Biologics, and Advanced Medicines to Patients Faster
Envol has long been at the forefront of nonclinical research for biologics, gene therapy, metabolic disease, CNS disorders, and respiratory diseases. Its deep expertise in anti-AAV and neutralizing antibody screening, repeated biopsies, surgical excisions, and GLP-compliant toxicology studies has made it an essential partner for sponsors developing cutting-edge therapies.
Now, with the backing of the LNP Alliance, Envol’s clients gain:
- Faster development timelines through integrated services and reduced handoff delays
- Better data packages for IND-enabling studies, supported by the alliance’s advanced formulation, analytical, and imaging capabilities
- A competitive edge in navigating regulatory pathways and accelerating first-in-human trials
Jake McDonald, CEO of Envol Biomedical, summed it up best:
“Our partnership in the LNP Alliance is an exciting leap forward—not just for Envol, but for every client we serve. We are strengthening our commitment to innovation, speed, and care, and empowering our partners to deliver life-changing therapies to patients worldwide.”
A Unified Vision for the Future
The LNP Alliance represents more than just a business partnership—it’s a shared commitment to advancing science, solving the toughest drug development challenges, and improving patient outcomes. Envol Biomedical’s role in this alliance underscores its mission to deliver exceptional science with a human touch, combining world-class technical expertise with a culture of care and collaboration.
For current and future Envol clients, this means:
- Broader services
- Deeper scientific support
- Faster, smarter pathways to success
Interested in learning how the LNP Alliance can accelerate your program?
Contact us today at LNPalliance@phosphorex.com or visit www.envolbio.com to explore partnership opportunities.